SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-004161
Filing Date
2024-01-29
Accepted
2024-01-29 16:30:18
Documents
17
Period of Report
2024-01-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50751
2 ex99.htm EX-99 16841
3 ex99_001.jpg GRAPHIC 5707
  Complete submission text file 0001493152-24-004161.txt   305914

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE hrow-20240126.xsd EX-101.SCH 3944
5 XBRL DEFINITION FILE hrow-20240126_def.xml EX-101.DEF 26962
6 XBRL LABEL FILE hrow-20240126_lab.xml EX-101.LAB 37217
7 XBRL PRESENTATION FILE hrow-20240126_pre.xml EX-101.PRE 25582
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6565
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 24574096
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)